Search Results - M. O. Panasenko

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics

    Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics by B. B. Samura, M. O. Panasenko

    Published 2020-03-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Comorbidities in patients with multiple myeloma

    Comorbidities in patients with multiple myeloma by L. P. Kuznetsova, M. O. Panasenko

    Published 2019-08-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Antitumor treatment and cardiohemodynamics in patients with multiple myeloma depending on renal function

    Antitumor treatment and cardiohemodynamics in patients with multiple myeloma depending on renal function by B. B. Samura, M. O. Panasenko

    Published 2020-08-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    4-phenyl-5-((pyrimidin-2-ylthio)methyl)-1,2,4-triazole-3-thiol as a platform for the synthesis of unsymmetrical disulfides

    4-phenyl-5-((pyrimidin-2-ylthio)methyl)-1,2,4-triazole-3-thiol as a platform for the synthesis of unsymmetrical disulfides by Yu. V. Karpenko, M. O. Panasenko

    Published 2025-03-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Cariohemodynamics in patients with multiple myeloma depending on renal function

    Cariohemodynamics in patients with multiple myeloma depending on renal function by B. B. Samura, M. O. Panasenko

    Published 2019-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma

    Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma by M. O. Panasenko, B. B. Samura, S. Ya. Dotsenko

    Published 2022-08-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Multiple myeloma and cardiovascular risk (a literature review)

    Multiple myeloma and cardiovascular risk (a literature review) by B. B. Samura, M. O. Panasenko, S. Ya. Dotsenko

    Published 2020-11-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Prognostic value of P-selectin and sST2 in patients with multiple myeloma

    Prognostic value of P-selectin and sST2 in patients with multiple myeloma by M. O. Panasenko, B. B. Samura, S. Ya. Dotsenko

    Published 2022-11-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    P-selectin and sST2 as prognostic biomarkers of cardiovascular events in patients with multiple myeloma following anticancer therapy and severe COVID-19

    P-selectin and sST2 as prognostic biomarkers of cardiovascular events in patients with multiple myeloma following anticancer therapy and severe COVID-19 by B. B. Samura, M. O. Panasenko, T. O. Samura, I. V. Chorna

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Structural-geometric and functional indicators of the heart in patients with multiple myeloma after anti-tumor treatment and COVID-19

    Structural-geometric and functional indicators of the heart in patients with multiple myeloma after anti-tumor treatment and COVID-19 by B. B. Samura, M. O. Panasenko, T. O. Samura, I. V. Chorna

    Published 2025-03-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: